BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30344176)

  • 1. Influence of social determinants of health on patients with advanced lung cancer: a prospective cohort study.
    Takemura T; Kataoka Y; Okazaki K; Sakurai A; Imakita T; Ikegaki S; Matsumoto H; Saito E; Takata H; Kaku S; Wada N; Shinomiya M; Otoshi T; Shimada M; Nikaido J; Iki R; Hirano K; Hirai T; Endo K; Naganuma T
    BMJ Open; 2018 Oct; 8(10):e023152. PubMed ID: 30344176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of loneliness and social isolation on the diagnosis and treatment of Japanese patients with advanced lung cancer: a prospective cohort study.
    Takemura T; Kataoka Y; Shirakawa C; Okazaki K; Sakurai A; Imakita T; Ikegaki S; Matsumoto H; Saito E; Takata H; Kaku S; Wada N; Shinomiya M; Otoshi T; Shimada M; Nikaido J; Iki R; Hirano K; Hirai T; Endo K; Hirabayashi M; Naganuma T
    Ann Palliat Med; 2021 Jun; 10(6):6236-6246. PubMed ID: 34118842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of social isolation and loneliness on the prognosis of advanced lung cancer patients: a prospective cohort study.
    Takemura T; Kataoka Y; Ashi N; Shirakawa C; Okazaki K; Sakurai A; Imakita T; Ikegaki S; Matsumoto H; Saito E; Takata H; Kaku S; Wada N; Shinomiya M; Otoshi T; Shimada M; Nikaido J; Iki R; Hirano K; Hirai T; Endo K; Hirabayashi M; Naganuma T
    Support Care Cancer; 2022 Jul; 30(7):6045-6053. PubMed ID: 35416501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.
    Beckett P; Tata LJ; Hubbard RB
    Lung Cancer; 2014 Mar; 83(3):396-400. PubMed ID: 24457105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social determinants of health and 5-year survival of colorectal cancer.
    Heidarnia MA; Monfared ED; Akbari ME; Yavari P; Amanpour F; Mohseni M
    Asian Pac J Cancer Prev; 2013; 14(9):5111-6. PubMed ID: 24175785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
    Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
    Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social determinants of lung cancer incidence in Canada: A 13-year prospective study.
    Mitra D; Shaw A; Tjepkema M; Peters P
    Health Rep; 2015 Jun; 26(6):12-20. PubMed ID: 26086335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database.
    Fairhurst C; Watt I; Martin F; Bland M; Brackenbury WJ
    BMJ Open; 2014 Nov; 4(11):e006604. PubMed ID: 25398679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
    Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
    J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.
    Crétel-Durand E; Nouguerède E; Le Caer H; Rousseau F; Retornaz F; Guillem O; Couderc AL; Greillier L; Norguet E; Cécile M; Boulahssass R; Le Caer F; Tournier S; Butaud C; Guillet P; Nahon S; Poudens L; Kirscher S; Loubière S; Diaz N; Dhorne J; Auquier P; Baumstarck K
    Trials; 2017 Apr; 18(1):174. PubMed ID: 28403911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial.
    Neychev V; Steinberg SM; Cottle-Delisle C; Merkel R; Nilubol N; Yao J; Meltzer P; Pacak K; Marx S; Kebebew E
    BMJ Open; 2015 May; 5(5):e008248. PubMed ID: 25991462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study on the social determinants of health: Tehran University of Medical Sciences employees` cohort (TEC) study protocol.
    Nedjat S; Mehrdad R; Yunesian M; Pouragha H; Biagi V; Monazzam-Esmaeelpour MR
    BMC Public Health; 2020 Nov; 20(1):1703. PubMed ID: 33187513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Medical Risk Factors as Avoidable Determinants of Excess Mortality in Children with Chronic Kidney Disease. A Prospective Cohort Study in Nicaragua, a Model Low Income Country.
    Montini G; Edefonti A; Galán YS; Sandoval Díaz M; Medina Manzanarez M; Marra G; Robusto F; Tognoni G; Sereni F
    PLoS One; 2016; 11(5):e0153963. PubMed ID: 27171479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
    Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
    Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
    Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
    Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
    Johnson AM; Hines RB; Johnson JA; Bayakly AR
    Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
    Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
    J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
    Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.